Intensive cholesterol control in high risk patients can reduce cardiovascular events by 20%

Median survival of patients on long term pharmacologic therapies with statins for secondary prevention was prolonged for only 4 days!
Analysis of randomised trials, Level of Evidence I.
Reference
bmjopen.bmj.com/content/5/9/e007118